# uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer

> **NCT02960724** · PHASE2 · UNKNOWN · sponsor: **Rigshospitalet, Denmark** · enrollment: 90 (estimated)

## Conditions studied

- Oral Cancer
- Oropharyngeal Cancer
- Neoplasms
- Head and Neck Neoplasms
- Cancer of Mouth
- Neoplasms by Site

## Interventions

- **OTHER:** 68Ga-NOTA-AE105 PET/CT

## Key facts

- **NCT ID:** NCT02960724
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2016-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02960724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02960724, "uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02960724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*